We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

DSM and DecImmune Therapeutics Sign Agreement

News   Apr 22, 2013

 
DSM and DecImmune Therapeutics Sign Agreement
 
 
 

RELATED ARTICLES

Sprouty 1 and Sprouty 2 Offer Potential to Combat Cancer

News

Two molecules, Sprouty 1 and Sprouty 2, modify the survival of effector T cells and the development of memory CD8 T cells. These findings offer promising potential for immunotherapeutic strategies to combat cancer and chronic infections.

READ MORE

A Cup of Strawberries a Day Keeps the Doctor Away

News

Less than a cup of strawberries a day could mitigate colonic inflammation for IBD sufferers and improve gut health.

READ MORE

Antibiotic Candidates Discovered

News

MIT researchers have discovered that peptides normally secreted by cells that line the stomach have previously unknown antimicrobial activity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE